Based on the marked antigenic similarities that exist between antigens of the human and bovine strains of respiratory syncytial virus (RSV), an enzyme immunoassay (EIA) designed to detect human RSV was used to detect bovine RSV. The commercial test kit (RSV EIA) consists of a solid phase (beads) coated with a capture antiserum prepared against the Long strain of human RSV.
The infection caused by bovine respiratory syncytial virus (BRSV) is one of the leading causes of bovine respiratory disease (BRD) in beef and dairy cattle. 2, 17 The existence of the virus has been inferred since the late 1960's. 5 However, in the last decade the role of this agent as the cause of BRD became evident. 2, 17 The improvements in techniques for the diagnosis of BRSV have contributed to increased recognition. 1, 2 Nevertheless, the accurate diagnosis of infections caused by this fastidious agent remains difficult. 1 Routine viral isolation techniques are inadequate for detecting infectious BRSV in clinical samples because the virus is too labile to survive under the conditions of transportation. 1, 2 In addition, interpretation of conventional serology is often difficult because of interference by passively acquired maternal antibodies. 1 Therefore, the methods for the direct detection of viral antigens in the clinical sample are the reference standard for the etiological diagnosis of BRSV infections.' The recent availability of specific monoclonal antibodies has helped to standardize the fluorescent antibody (FA) test,* which is particularly useful on post-mortem lung tissue samples.' The FA test on fresh viable cells from respiratory tract washings is a sensitive procedure for detecting human respiratory syncytial virus 3 and BRSV. 7 Although this procedure is commonly used in human hospitals, it is not satisfactory under the conditions of a veterinary diagnostic laboratory.
Recently, a commercial respiratory syncytial virus (RSV) enzyme immunoassay (EIA) has been described as being successful for the direct detection of human RSV antigens in nasopharyngeal washes, aspirates, and swabs. 4, 9, 19 Extensive antigen cross-reactivity exists between human and cattle strains of RSV. 12, 16, 18, 20 T h e objective of this study was to determine the diagnostic accuracy of RSV EIA in detecting BRSV by comparison with other methods used in our laboratory.
Materials and methods
Clinical specimens. Investigation for BRSV detection was performed for a period of 22 mo on fresh (unfixed) samples of bovine lungs from cases of BRD received at the Veterinary Diagnostic Center, University of Nebraska-Lincoln. Although some material came from necropsies performed at the laboratory, most arrived by mail. In general, the material was received under refrigeration. The sampling and processing of the lung tissue for FA test has been described previously. 1 Viral isolation attempts and RSV EIA were performed on homogenates of lung tissues. A 20% (w/v) suspension of lung tissues was prepared in minimal essential medium (MEM) containing 2% horse serum, 300 IU/ml pen-icillin, 300 µg/ml streptomycin, and 300 µg/ml kanamycin. After thorough mechanical disintegration of the tissues (using scissors followed by treatment through a tissue disintegrator" for 2 min), the suspension was centrifuged at 2,000 x g for 10 min at 4 C. The supernatant was collected and used for viral isolation attempts and for RSV EIA. b The samples that could not be assayed immediately were frozen at -80 C.
Nasal samples from field cases of BRD were collected using the regular type of swab and viral transport medium provided by our laboratory. These consist of a cotton-tipped wooden applicator in a volume of 2 ml of MEM containing 2% horse serum, 100 µg/ml gentamicin, and 30 µg/ml amphotericin B. In general, the samples were received refrigerated and were used for both viral isolation procedures and RSV EIA.
Experimental infections. Three calves were used for experimental inoculation with bovine RSV. The calves were delivered by cesarean section and kept in a sterile environment for 4 wk, followed by 45 days of rearing under strict (non-sterile) isolation. The animals were inoculated by intranasal instillation of 10 6 plaque-forming units of strain 375 of BRSV. Nasal samples were collected every 12 hr until day 5 postinoculation and daily afterwards. The samples were processed immediately for viral isolation and RSV EIA or frozen at -80 C until simultaneous testing of viral isolation and RSV EIA. At day 10 postinoculation, the animals were killed and the respiratory tissues collected as described.'
Virus and cell cultures. Bovine viral diarrhea virus (BVDV)-free strain 375 of BRSV was used for laboratory propagation on cell cultures and for animal inoculations. Bovine turbinate (BT) cells, free of BVDV, were used. d Virus isolation. The viral isolation attempts performed on the clinical samples obtained from field cases and from animals infected experimentally with BRSV were carried out using the procedure of centrifugal enhancement of infectivity previously described for bovine herpesvirus-1 (BHV-1) isolation. 11 Bovine turbinate cells and primary newborn calf lung cells (between passage nos. 1 and 5) were used. Fifty percent end-point titration of the infectious BRSV, contained in each nasal sample of experimentally infected cattle, was performed. 14 The identity of all viral isolates recovered from clinical samples was confirmed by standard FA staining using conjugates." Alternatively, a neutralization test was performed using specific hyperimmune serums. e Antisera. Hyperimmune serum against BRSV produced in gnotobiotic calves was used. e Monoclonal antibodies. A pool of ascites fluids, composed of 2 neutralizing (8G12 and 15C7) and 2 non-neutralizing (6A12 and 14E3) monoclonal antibodies specific for bovine RSV8, was used as blocking antibody for the confirmation of positive EIA samples (see below).
EIA. The RSV EIA test was performed according to the instructions provided by the manufacturer. b At least 3 known BRSV-negative samples plus the corresponding positive and negative controls provided with the kit were assayed together with the test specimens. The absorbance of the reaction was read in a spectrophotometer. b According to the instructions provided with the kit, a run was considered valid if the negative controls were within 50% of their mean value and the difference between the positive result and negative control mean was ≥0.6 absorbance units. A cutoff value was estab-lished as 0.12 absorbance units above the mean negative control. An optical density (O.D.) of ± 7% of the cutoff value was used to define a "grey zone" (borderline) according to the manufacturer's instructions. b The specimens exhibiting an EIA result within the "grey zone" were retested.
Blocking assay. The specificity of the RSV EIA for the detection of BRSV was further tested by means of a blocking test. Two different types of blocking antibodies were used: in some cases a hyperimmune serum anti-BRSV e was used, in others a pool of monoclonal antibodies against BRSV. 8 Either undiluted normal bovine fetal serum or undiluted ascites fluid of a hybridoma that secretes monoclonal antibodies against bovine herpesvirus-1 g was used as normal (or "non-blocking") controls. Each positive specimen by the RSV EIA was retested in duplicate: One 200-µ1 sample was preincubated with 20 µ1 of undiluted blocking antibody for 2 hr at 37 C, another 200-µ1 aliquot was preincubated with 20 µ1 of undiluted normal antibody. Following these preincubations, the samples were retested using the routine EIA protocol described above. Each blocking assay also included negative and positive control samples provided with the kit. A sample was confirmed as positive for RSV EIA if the blocked sample showed a ≥ 50% reduction in O.D. compared with the normal control.
FA test. The direct FA staining on cryostat section of fresh frozen lung samples was performed essentially as described. l The conjugate used for the FA test consisted of BRSV-specific monoclonal antibody conjugated to fluorescein isothiocyanate. 1, 8 
Results
Assessment of the sensitivity of the RSV EIA to detect infectious RSV in cattle. (a) Assay with cell culturepropagated BRSV: Serial lo-fold dilutions of a laboratory stock of strain 375 of BRSV (35th passage in BT cells) were used for a preliminary assessment of the sensitivity of the RSV EIA. The RSV EIA detected the virus in several dilutions of the virus. These detections were specific, as confirmed by a blocking assay that used bovine hyperimmune serum against bovine RSV. The threshold of detection (i.e., lowest concentration of virus displaying a positive EIA reaction) exhibited by the EIA was ≤ 102.3 CCID 50 /ml.
(b) Assay with nasal samples from experimentally infected animals: The BRSV infectious titers contained in the nasal samples collected during a l0-day period following experimental infection of 3 calves are shown in Fig. 1 . Each titer is plotted in function of the corresponding O.D. exhibited by the sample when tested by the RSV EIA. Of 48 nasal samples, 30 exhibited a measurable infectious titer. Infectious titers ranged from ≤ 10 1.53 to 10 3.75 CCID 50 /ml ( Fig. 1 ). Of 30 samples in which BRSV was detectable by virus isolation, 24 tested positive by RSV EIA. This is a relative sensitivity of the RSV EIA of 80% (24 samples that tested positive by EIA/30 samples that tested positive by virus isolation x 100 = 80%). At the same time, no sample All the nasal samples that tested positive by RSV EIA (with the exception of 1; Fig. 1 ) exhibited an infectious titer above the previously defined detection threshold of the EIA for cell culture-propagated BRSV (Fig. 1 ).
Comparison of the RSV EIA with the FA test on lung tissues.
A total of 251 lung samples were examined by FA and RSV EIA. These samples were regular submissions to our diagnostic laboratory for a period of 2 years and corresponded to clinical cases with general diagnosis of BRD. Of these, 63 (25%) were positive by RSV EIA and 37 ( 14.7%) were positive by FA ( Table  1 ). All of the samples that initially tested positive by RSV EIA were confirmed by blocking assay. To compare the 2 tests, we evaluated the FA test versus the RSV EIA in its sensitivity and specificity and also the percentage of overall agreement between the 2 tests. The results were 58.7, 100, and 89.6%, respectively ( Table 1) .
Verification of the specificity of detection of BRSV using the RSV EIA. All the specimens that tested positive by the RSV EIA were verified by means of a blocking assay. The typical O.D. readings of the blocking assay obtained on some of the positive EIA lung homogenates and nasal samples are shown in Table 2 . Positive blocking or neutralization of the EIA took place when a BRSV-specific antiserum or a pool of BRSV-specific monoclonal antibodies were used to pretreat the sample ( Table 2) . No significant decrease in the intensity of the color reaction took place after preincubation of those samples with normal bovine fetal serum or with a monoclonal antibody specific for BHV-1.
Detection of BRSV in nasal samples. A total of 137
nasal samples from cases of BRD were examined by RSV EIA. Of these, 38 (27.7%) tested positive and were confirmed by blocking assay.
Isolation of other viruses from the clinical samples.
Several other viruses were isolated from some of the 251 lung samples and 137 nasal samples that were tested. The frequency of the virus isolations was consistent with previous diagnostic findings in the region and with the expected seasonal incidence for each virus. These isolations included 68 noncytopathic BVDV from lungs and 48 from nasal swabs, 5 cytopathic BVDV from lungs, 47 BHV-1 from lungs and 38 from nasal swabs, 2 bovine adenovirus type 3 from lungs, 3 parainfluenza-3 viruses from lungs and 2 from nasal swabs, and 1 picorna-like virus from a lung that was tentatively identified as an entero-or rhinovirus. In several cases one of these viruses was isolated simultaneously with the positive detection of bovine RSV in the same sample using EIA (alone or in conjunction with FA). These simultaneous diagnoses included 7 lung samples with noncytopathic BVDV, 3 lung samples with BHV-1, and 3 nasal samples with BHV-1.
Discussion
One characteristic of BRSV infections is that they exhibit no pathognomonic symptom or lesion. Although a presumptive diagnosis of BRSV infection may be implicated by clinical signs, epidemiologic features, and pathologic examination, a definitive diagnosis is not possible without laboratory confirmation. Because cell culture isolation methods for BRSV are inadequate, the direct detection of BRSV antigens in the clinical sample (i.e., FA test) have become the diagnostic standard for the identification of these viral infections. The results of this study have shown that the RSV EIA test is substantially better than the FA test for the identification of BRSV in clinical samples.
The RSV EIA was developed for the detection of human RSV in upper respiratory tract secretions. However, RSV EIA exhibited high sensitivity for the detection of BRSV in both nasal secretions and lung homogenates of cattle. The results of this EIA are accepted as being specific for BRSV based on 2 sets of data: (1) the ability of BRSV-specific reagents (both a polyclonal serum and a pool of monoclonal antibodies) to inhibit significantly and specifically the EIA reaction, and (2) the close agreement existing between the RSV EIA and the FA test, which are performed with BRSV-specific conjugates. The data also confirm previous reports on the significant antigenic cross reactivity that exists among several polypeptides of the human and cattle strains of RSV. 5, 12, 16, 18, 20 The F protein in particular seems to be the most conserved polypeptide among the different species-specific strains. l6 In this study, more virus-positive samples were detected from experimentally BRSV-infected cattle by isolation techniques than by the RSV EIA. However, regional veterinary diagnostic laboratories generally do not receive adequate specimens for the cultivation of BRSV. Contrary to the recommended conditions for isolation of infectious BRSV, 1 the RSV EIA procedure does not require any special medium for collecting and transporting the sample. Previous reports have indicated that the antigens of RSV are fairly stable under common conditions of transportation. l0 An additional advantage of the RSV EIA is that the test permits a rapid antemortem diagnosis of BRSV with a high level of sensitivity. Two other diagnostic methods that are suitable for rapid diagnosis are the BRSV-specific IgM detection 21 and FA analysis of lung lavage cells. 7 However, the collection and submission of lung and tracheal lavage cells are not practical under field conditions. In addition, the collection and fixation of upper respiratory tract cells for FA detection of BRSV has proven to be difficult to standardize and interpret.'
The threshold for detection of BRSV achieved by RSV EIA is comparable to that of other rapid immunoassays that are used to detect viral antigens. 15 Although its sensitivity is less than that of culture methods, the RSV EIA may permit a rapid diagnosis (≤6 hr) with greater sensitivity than the FA test. The RSV EIA detected BRSV infections more frequently than the previous methods. It is interesting that the frequency of BRSV detection using RSV EIA is comparable to the frequency of isolation of BVDV and BHV-1, both well-known respiratory pathogens of cattle. This supports the importance of BRSV as a cause of BRD. 2, 17 Our simultaneous recovery of BRSV and other respiratory viruses (specifically BVDV and BHV-1) are interesting. These data may support speculation on the possible interaction or association between different respiratory viruses in the causation or enhancement of BRD. This relationship has already been reported to exist between BVDV and BHV-1. 13 
